- Home
- BNTX vs LII Comparison
BNTX vs LII Comparison
Compare BNTX & LII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTX
- LII
- Stock Information
- Founded
- BNTX 2008
- LII 1895
- Country
- BNTX Germany
- LII United States
- Employees
- BNTX N/A
- LII N/A
- Industry
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- LII Industrial Machinery/Components
- Sector
- BNTX Health Care
- LII Industrials
- Exchange
- BNTX Nasdaq
- LII Nasdaq
- Market Cap
- BNTX 26.4B
- LII 20.3B
- IPO Year
- BNTX 2019
- LII 1999
- Fundamental
- Price
- BNTX $99.26
- LII $550.18
- Analyst Decision
- BNTX Strong Buy
- LII Hold
- Analyst Count
- BNTX 18
- LII 12
- Target Price
- BNTX $139.49
- LII $647.82
- AVG Volume (30 Days)
- BNTX 1.2M
- LII 401.3K
- Earning Date
- BNTX 11-03-2025
- LII 10-22-2025
- Dividend Yield
- BNTX N/A
- LII 0.95%
- EPS Growth
- BNTX N/A
- LII 29.66
- EPS
- BNTX N/A
- LII 23.38
- Revenue
- BNTX $3,380,387,551.00
- LII $5,416,600,000.00
- Revenue This Year
- BNTX N/A
- LII $3.40
- Revenue Next Year
- BNTX $13.50
- LII $6.26
- P/E Ratio
- BNTX N/A
- LII $23.53
- Revenue Growth
- BNTX 6.98
- LII 7.91
- 52 Week Low
- BNTX $81.20
- LII $500.10
- 52 Week High
- BNTX $131.49
- LII $689.44
- Technical
- Relative Strength Index (RSI)
- BNTX 50.29
- LII 41.96
- Support Level
- BNTX N/A
- LII $541.87
- Resistance Level
- BNTX $104.48
- LII $577.20
- Average True Range (ATR)
- BNTX 3.81
- LII 15.37
- MACD
- BNTX -4.06
- LII -0.44
- Stochastic Oscillator
- BNTX 86.40
- LII 29.15
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
About LII Lennox International Inc.
Lennox International manufactures and distributes heating, ventilating, air conditioning, and refrigeration products to replacement (75% of sales) and new construction (25% of sales) markets. In fiscal 2024, residential HVAC was 67% of sales and commercial HVAC and Heatcraft refrigeration was 33% of sales. The company goes to market with multiple brands, but Lennox is the company's flagship HVAC brand. The Texas-based company is focused on North America after the sale of its European HVAC and refrigeration businesses in late 2023.